Tag: Biohaven shares

Enterprise, Industries

Pfizer to pay $11.6 billion for Biohaven to tap migraine market

May 10, 2022


Pfizer Inc (NYSE:PFE) said on Tuesday it will pay $11.6 billion to buy Biohaven Pharmaceutical Holding Co (NYSE:BHVN), making a big bet its ability to boost sales of the top-selling pill in a new class of migraine drugs. The boards […]